Barry Borlaug, Mayo Clinic: Heart Failure With Preserved Ejection Fraction
While there's no yet proven treatment for heart failure with preserved ejection fraction, the team is really aiming to understand the pathophysiology to design better targeted treatments.
At the Heart Failure Society of America's 20th Annual Scientific Meeting in Orlando, Fl., Barry Borlaug, MD, Mayo Clinic, discussed his fascination with the relaxation of the heart and his latest research in heart failure with preserved ejection fraction. While there's no proven treatment, the team is really aiming to understand the pathophysiology to design better treatments. For now, the team is limited to controlling blood pressure and any diuretics and treating any of their other conditions until they can find more targeted treatments.
Related Videos
Related Content
